Biochemical and pharmacological studies with asparaginase in man.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000378:metabolism* / Q000627:therapeutic use / Q000633:toxicity; D001215:Asparaginase / Q000378:metabolism* / Q000627:therapeutic use / Q000633:toxicity; D001216:Asparagine / Q000097:blood; D001224:Aspartic Acid / Q000097:blood; D002648:Child; D003110:Colonic Neoplasms / Q000378:metabolism; D004926:Escherichia coli / Q000201:enzymology; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000378:metabolism*; D007945:Leukemia, Lymphoid / Q000378:metabolism; D007951:Leukemia, Myeloid / Q000378:metabolism; D015470:Leukemia, Myeloid, Acute / Q000378:metabolism; D008228:Lymphoma, Non-Hodgkin / Q000378:metabolism; D008297:Male; D008545:Melanoma / Q000378:metabolism; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D009101:Multiple Myeloma / Q000378:metabolism; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D009447:Neuroblastoma / Q000378:metabolism; D012516:Osteosarcoma / Q000378:metabolism
D000970:Antineoplastic Agents; D001224:Aspartic Acid; D001216:Asparagine; D001215:Asparaginase